Jakub Jóźwicki

Alterations in 5hmC and TET2 expression in bladder cancer and their associations with clinicopathological features and patient outcome

Abstract Bladder cancer (BLCA) remains a major clinical challenge due to its high recurrence rate and the limited availability of reliable prognostic biomarkers. Since epigenetic dysregulation is a hallmark of urothelial carcinogenesis, we investigated the expression patterns, cl...